Immediate Impact
16 standout
Citing Papers
Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma
2024 Standout
[177Lu]Lu-DOTA-TATE plus long-acting octreotide versus high‑dose long-acting octreotide for the treatment of newly diagnosed, advanced grade 2–3, well-differentiated, gastroenteropancreatic neuroendocrine tumours (NETTER-2): an open-label, randomised, phase 3 study
2024 Standout
Works of Deepak Sudheendra being referenced
Chronic Hepatotoxicity in Patients with Metastatic Neuroendocrine Tumor: Transarterial Chemoembolization versus Transarterial Radioembolization
2020
Association of Complete Radiologic and Pathologic Response following Locoregional Therapy before Liver Transplantation with Long-Term Outcomes of Hepatocellular Carcinoma: A Retrospective Study
2019
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Deepak Sudheendra | 117 | 86 | 117 | 112 | 28 | 306 | |
| Zubin Irani | 132 | 97 | 115 | 65 | 34 | 317 | |
| Brandt C. Wible | 92 | 118 | 66 | 104 | 17 | 276 | |
| Ambarish P. Bhat | 135 | 96 | 25 | 50 | 38 | 319 | |
| Larry‐Stuart Deutsch | 133 | 140 | 45 | 32 | 21 | 335 | |
| Jorge Eduardo de Amorim | 209 | 98 | 51 | 86 | 36 | 286 | |
| Mark L. Lessne | 120 | 120 | 78 | 124 | 32 | 363 | |
| Jostein Gleditsch | 99 | 91 | 31 | 157 | 28 | 339 | |
| Hearns W. Charles | 118 | 123 | 54 | 55 | 37 | 330 | |
| Eunice Moon | 155 | 49 | 114 | 171 | 18 | 300 | |
| Jane Phillips‐Hughes | 244 | 248 | 37 | 44 | 18 | 348 |
All Works
Login with ORCID to disown or claim papers
Loading papers...